William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza
Since 1998 Baker Ruskinn have been working with pioneering scientists around the world to make breakthroughs in cell research. Over those years, researchers have devoted their lives to advancing knowledge and understanding of the way cells behave. And that means from day one you have to be confident that your results can be trusted.
Earlier today (Monday October 7 at 11.30am GMT), The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza "for their discoveries of how cells sense and adapt to oxygen availability."
Both William G. Kaelin Jr and Sir Peter J. Ratcliffe are long standing customers of Baker Ruskinn. Their discoveries of how cells behave were made possible by the revolutionary technology pioneered by Ruskinn Technology Ltd (now recognized as Baker Ruskinn).
Baker Ruskinn are extremely proud to have been a part of the journey that has resulted in The Nobel Prize for William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza.
In 1988, Andrew Skinn (founder of Ruskinn Technology Ltd) collaborated with Sir Peter J. Ratcliffe and his team with a vision to develop precision control oxygen technolgoy with the launch of InvivO2. The InvivO2 workstation was designed and built to mimic the physiology of your subject matter, giving you the reassurance of precise results under controlled conditions. It allows you to study the most complex of cell interactions under precise physiological conditions, regulating and maintaining oxygen, carbon dioxide, temperature and humidity.
At Baker Ruskinn we believe that with remarkable minds and exceptional tools, we can achieve great things. We know these kinds of breakthroughs are rarely made overnight. We know it can take years of hard work and dedication. We know you rely on us to make sure every detail is perfect. That’s why all our products are designed with precision craftsmanship and rigorously tested.